J. Craig Venter Institute, also known as JCVI, is a privately owned, US-based research institute founded in 1992, employing approximately 200 individuals. The institute specializes in biotechnology research, primarily focusing on genomic research.
On June 22, 2026, scientists studied a tiny, abundant ocean alga, revealing how life thrives in challenging environments like the subsurface chlorophyll maximum layer (SCML), a dim zone below the surface where sunlight and iron are scarce. Earlier, on June 12, JCVI recommended making NHS pneumococcal and seasonal flu vaccinations available to homeless individuals to provide better protection through winter and reduce flu spread among vulnerable groups. This followed a June 1 discussion exploring synthetic biology, which highlighted humanity's newfound ability to "write new versions" of the book of life, along with the inherent power and peril of changing the natural world. Previously, on May 17, Craig Venter discussed his ambitious goals in genomics and synthetic biology, including his "modest goals of replacing the whole petrochemical industry."
Similar Companies
Subscribe for full access to J. Craig Venter Institute (JCVI)'s profile
Subscribe for full access to J. Craig Venter Institute (JCVI)'s products in full detail
Subscribe for full access to J. Craig Venter Institute (JCVI)'s revenue in full detail
Subscribe for full access to J. Craig Venter Institute (JCVI)'s products in full detail 
